Related Experiment Video
Updated: Jan 3, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary Arterial Hypertension in Hispanics
1Pulmonary Medicine, Aventura Hospital and Medical Center, Aventura, USA.
Pulmonary arterial hypertension (PAH) affects Hispanics differently, yet data on this group is scarce. More research is needed to understand and improve PAH treatment for Hispanic populations.
Area of Science:
- Cardiology
- Pulmonology
- Epidemiology
Background:
- Pulmonary hypertension (PH) involves elevated pulmonary vessel pressures.
- Pulmonary arterial hypertension (PAH) is a specific pre-capillary form of PH.
- PAH prevalence is approximately 15 cases per million, often idiopathic.
Purpose of the Study:
- To review limited data on PAH in Hispanic populations.
- To examine etiology, diagnosis, and treatment in South and Central American Hispanics.
- To analyze PAH data for US-based Hispanics and compare with other ethnicities.
Main Methods:
- Literature review of available epidemiological and clinical data.
- Analysis of information from South American and Central American countries.
- Examination of data for Hispanics diagnosed with PAH in the United States.
Main Results:
- Significant gaps exist in understanding PAH epidemiology and treatment response in Hispanic populations.
- Cultural, environmental, and genetic factors may influence PAH manifestation and treatment outcomes.
- Current data primarily originates from US and European registries, with limited ethnic diversity.
Conclusions:
- There is a critical need for more research on PAH in Hispanic individuals.
- Understanding ethnic-specific differences is crucial for tailoring effective PAH treatments.
- Addressing data limitations can improve health outcomes for Hispanics with PAH.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Other Pulmonary Disorders

